These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2818620)

  • 21. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
    Nakajima Y; Iigo M; Hoshi A
    Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP).
    Sun YW; Chen KM; Kwon CH
    Mol Pharm; 2006; 3(2):161-73. PubMed ID: 16579645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
    Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
    Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y
    Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the rational development of a new drug: the example of the fluorinated pyrimidines.
    Heidelberger C
    Cancer Treat Rep; 1981; 65 Suppl 3():3-9. PubMed ID: 7346154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
    Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
    Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphorus-31 nuclear magnetic resonance studies of complexes of thymidylate synthase.
    Connick TJ; Reilly RT; Dunlap RB; Ellis PD
    Biochim Biophys Acta; 1994 Sep; 1208(1):118-26. PubMed ID: 8086425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
    Tanaka M; Kimura K; Yoshida S
    Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the interaction with thymidylate synthase of analogues of 2'-deoxyuridine-5'-phosphate and 5-fluoro-2'-deoxyuridine-5'-phosphate with modified phosphate groups.
    Rode W; Kulikowski T; Kedzierska B; Shugar D
    Biochem Pharmacol; 1987 Jan; 36(2):203-10. PubMed ID: 3814166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thymidine and thymidylate analogs on nucleic acid synthesis in tumor cells.
    Toide H; Akiyoshi H; Minato Y; Fujii S
    Gan; 1977 Apr; 68(2):159-63. PubMed ID: 892290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro.
    Agarwal RP; Mian AM
    Biochem Pharmacol; 1991 Jul; 42(4):905-11. PubMed ID: 1867645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.
    De Flora A; Zocchi E; Guida L; Polvani C; Benatti U
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3145-9. PubMed ID: 2966399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
    Fernandes DJ; Cranford SK
    Biochem Pharmacol; 1985 Jan; 34(1):125-32. PubMed ID: 3155614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of 5-fluoro-4-thio-2'-deoxyuridine 5'-phosphate with mammalian tumour thymidylate synthase: role of the pyrimidine N(3)-H dissociation.
    Dzik JM; Kulikowski T; Zielinski Z; Ciesla J; Rode W; Shugar D
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1200-7. PubMed ID: 3480707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidylate synthetase activity and fluorouracil sensitivity of human colonic cancer and normal mucosal tissue preparations.
    Wolberg WH; Morin J
    Cancer; 1981 Mar; 47(6):1313-7. PubMed ID: 7226054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil.
    Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of resistance to fluoropyrimidines.
    Zhang ZG; Harstrick A; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and interactions with thymidylate synthase of 2,4-dithio analogues of dUMP and 5-fluoro-dUMP.
    Dzik JM; Bretner M; Kulikowski T; Gołos B; Jarmuła A; Poznański J; Rode W; Shugar D
    Biochim Biophys Acta; 1996 Mar; 1293(1):1-8. PubMed ID: 8652614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.